...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: A Swedish national register study
【24h】

Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: A Swedish national register study

机译:在成人患者中诊断的药理剂在成年患者中发育慢性形式的免疫血小板减少症:瑞典国家注册研究

获取原文
获取原文并翻译 | 示例

摘要

Abstract Patients with primary chronic immune thrombocytopenia (cITP) have been reported to use more anti-infective medications, even before diagnosis of immune thrombocytopenia (ITP). The more common use of anti-infective medications may be due to general health problems, requiring medication in the early stages of cITP and before the diagnosis is set, rather than infections preceding the disease. Accordingly, cITP may not only be associated with use of anti-infective medications but also with medications for more general symptoms. Objective To investigate use of medications for general symptoms, such as analgesics and vitamin supplements in patients with ITP developing the chronic form, the year preceding their first primary diagnosis in comparison with such use in the general population. Method Swedish Health Registers were used to identify adult patients (n=1087) with primary cITP during 2006–2012 and data on medications. Standardized Incidence Ratios (SIRs) and 95% confidence intervals (CI), were estimated as a measure of relative risk. Results The association for overall studied medications was SIR=1.36 (95% CI 1.32–1.41). A majority of the point estimates were above unity. Conclusion In patients with cITP, prescription fills for medications used to treat pain conditions and vitamin deficiencies are more common in the year preceding their first diagnosis as compared with prescription fills in the general population. Our results suggest that patients later diagnosed with cITP receive treatment due to symptoms that could be signs of an early ITP. Accordingly, in investigations for unspecific pain symptoms and vitamin deficiencies, cITP should be considered as a differential diagnosis. Highlights ? Even before their first diagnosis, patients with chronic ITP have more prescription fills than the general population. ? More than 40% of cITP patients filled at least one prescription with a study medication the year preceding their first diagnosis. ? Patients with chronic ITP may seek help due to pain and more general symptoms.
机译:摘要据报道,原发性慢性免疫性血小板减少症(cITP)患者甚至在诊断为免疫性血小板减少症(ITP)之前就使用了更多的抗感染药物。抗感染药物的更常见使用可能是由于一般的健康问题,需要在cITP的早期阶段和确诊前用药,而不是在疾病之前的感染。因此,cITP可能不仅与抗感染药物的使用有关,还与治疗更一般症状的药物有关。目的调查慢性ITP患者在首次初步诊断前一年对一般症状的药物使用情况,如止痛剂和维生素补充剂,并与普通人群进行比较。方法使用瑞典健康登记簿,对2006-2012年间患有原发性cITP的成年患者(n=1087)和药物数据进行识别。标准化发病率(SIRs)和95%置信区间(CI)被估计为相对风险的衡量标准。结果总体研究药物的相关性为SIR=1.36(95%可信区间1.32–1.41)。大多数的点估计都高于统一。结论在cITP患者中,与普通人群中的处方药相比,用于治疗疼痛和维生素缺乏的药物的处方药在首次诊断前一年更为常见。我们的研究结果表明,后来被诊断为cITP的患者由于可能是早期ITP症状而接受治疗。因此,在对非特异性疼痛症状和维生素缺乏症的调查中,cITP应被视为一种鉴别诊断。亮点?即使在首次诊断之前,慢性ITP患者的处方药也比普通人群多?超过40%的cITP患者在首次诊断前一年至少服用了一种研究药物?慢性ITP患者可能会因疼痛和更普遍的症状寻求帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号